KRAS and neoplasm: Wang et al [31] investigated the KRAS mutation status in paired plasma and tumor tissue samples of 97 mCRC patients using NGS, and results showed concordance rate of 65.26%, sensitivity of 70.02%, and specificity of 66.71%.